Kang‐Il Kim
경희대학교 의학과 · 의학
김강일 교수의 연구실은 주로 관절 질환, 특히 무릎 골관절염과 골반 관절 이상을 중심으로 한 재생의료 및 수술적 치료 전략을 연구하고 있습니다. 자가 지방유래 간엽줄기세포의 관절내 주입 치료 효과와 열린 외측 웨지형 골절교정술(HTO)을 통한 연골 재생 메커니즘에 대한 임상적 연구가 핵심이며, 특히 비만도가 낮은 환자에서의 치료 성과가 뛰어나다는 점을 규명하고 있습니다. 또한, 골반관절 이명리와 연관된 관절내 병변을 동시에 진단하고 치료하는 병합 수술 전략의 유효성에 대해서도 연구를 진행하고 있습니다.
표시된 성과는 수집된 데이터 기준으로 산출되며, 일부 차이가 있을 수 있습니다.
Mesenchymal stem cells (MSCs) have been the focus of an emerging treatment for osteoarthritis. However, few studies reported about outcomes of an intra-articular injection of autologous adipose-derived mesenchymal stem cells (AD-MSCs). This study aimed to assess the efficacy and safety of a single intra-articular injection of AD-MSCs for patients with knee osteoarthritis. It was a prospective double-blinded, randomized controlled, phase IIb clinical trial. AD-MSCs were administered for 12 patien
This study replicated earlier work comparing reward allocation preferences across countries. Results obtained from student groups from the United States, Japan, and South Korea supported the earlie...
Therapeutic study, level V (expert opinion). See Guidelines for Authors for a complete description of levels of evidence.
NCT03990805 (ClinicalTrials.gov identifier).
Regeneration of degenerated articular cartilage in the medial compartment can be expected while correcting a varus deformity in arthritic knees after medial open-wedge HTO with a locked plate system without any additional cartilage regeneration procedures. Moreover, we suggest that medial open-wedge HTO in the medial arthritic knee with varus malalignment should be highly successful in terms of cartilage regeneration, especially for lower BMI patients.
Reconstructive acetabular osteotomy is a well established and effective procedure in the treatment of acetabular dysplasia. However, the dysplasia is frequently accompanied by intra-articular pathology such as labral tears. We intended to determine whether a concomitant hip arthroscopy with peri-acetabular rotational osteotomy could identify and treat intra-articular pathology associated with dysplasia and thereby produce a favourable outcome. We prospectively evaluated 43 consecutive hips treat
Level IV, therapeutic case series.
Therapeutic studies, level IV (case series). See the Guidelines for Authors for a complete description of levels of evidence.
These findings indicate that doxorubicin enhances transgene expression under the control of the CMV promoter and that doxorubicin might be used as an adjuvant to radioiodine therapy by NIS gene transfer in anaplastic thyroid carcinoma.
